
FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

Flow problems must be addressed using the combined approach of experimental and computational methods.

The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.

Part II of this article describes the installation, operational, and performance qualification of an autoclave and discusses a system for change control.

Cyclodextrins can improve the physiochemical properties of various sustained-release formulations.